Literature DB >> 20727886

Abdominal visceral adipose tissue volume is associated with increased risk of erosive esophagitis in men and women.

Su Youn Nam1, Il Ju Choi, Kum Hei Ryu, Bum Joon Park, Hyun Bum Kim, Byung-Ho Nam.   

Abstract

BACKGROUND & AIMS: Data on the association between erosive esophagitis and obesity are inconsistent because of variations in study populations and methods used to determine obesity.
METHODS: Participants in a prospective health-screening cohort underwent esophagogastroduodenoscopy and computed tomography. The association between erosive esophagitis and obesity (measured by body mass index [BMI], waist circumference, and abdominal visceral adipose tissue volume) was estimated with odds ratios (ORs) and 95% confidence intervals (CIs), adjusting for confounding factors. We also analyzed the association between obesity and erosive esophagitis by sex.
RESULTS: The prevalence of erosive esophagitis was 9.3% (495/5329). The OR for erosive esophagitis correlated with obesity measured by BMI, waist circumference, and abdominal visceral adipose tissue volume (P < .001 for each factor). The multivariate OR for erosive esophagitis was 1.97 (95% CI: 1.34-2.90) for a visceral adipose tissue volume of 500-999 cm(3), 2.27 (95% CI: 1.51-3.39) for 1000-1499 cm(3), and 2.94 (95% CI: 1.87-4.62) for ≥1500 cm(3), compared with participants who had visceral adipose tissue volumes less than 500 cm(3). When measures of obesity were analyzed simultaneously, abdominal visceral adipose tissue volume, but not BMI or waist circumference, was associated with erosive esophagitis. The 3 measures of obesity were significantly associated with erosive esophagitis in males, but only visceral adipose tissue volume was associated with erosive esophagitis in females (P = .002).
CONCLUSIONS: In contrast to BMI or waist circumference, abdominal visceral adipose tissue volume is associated with an increased risk of erosive esophagitis in males and females.
Copyright © 2010 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20727886     DOI: 10.1053/j.gastro.2010.08.019

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  47 in total

Review 1.  The role of obesity in oesophageal cancer development.

Authors:  Elizabeth Long; Ian L P Beales
Journal:  Therap Adv Gastroenterol       Date:  2014-11       Impact factor: 4.409

Review 2.  Central adiposity is associated with increased risk of esophageal inflammation, metaplasia, and adenocarcinoma: a systematic review and meta-analysis.

Authors:  Siddharth Singh; Anamay N Sharma; Mohammad Hassan Murad; Navtej S Buttar; Hashem B El-Serag; David A Katzka; Prasad G Iyer
Journal:  Clin Gastroenterol Hepatol       Date:  2013-05-22       Impact factor: 11.382

3.  Absolute reliability of adipose tissue volume measurement by computed tomography: application of low-dose scan and minimal detectable change--a phantom study.

Authors:  Takahiro Onuma; Tamotsu Kamishima; Tsukasa Sasaki; Motomichi Sakata
Journal:  Radiol Phys Technol       Date:  2015-06-09

Review 4.  Lifestyle measures in the management of gastro-oesophageal reflux disease: clinical and pathophysiological considerations.

Authors:  J H-E Kang; J Y Kang
Journal:  Ther Adv Chronic Dis       Date:  2015-03       Impact factor: 5.091

5.  Visceral abdominal obesity is associated with an increased risk of irritable bowel syndrome.

Authors:  Chang Geun Lee; Jun Kyu Lee; Yun-Seong Kang; Seungmin Shin; Jae Hak Kim; Yun Jeong Lim; Moon-Soo Koh; Jin Ho Lee; Hyoun Woo Kang
Journal:  Am J Gastroenterol       Date:  2015-01-13       Impact factor: 10.864

6.  Distribution of body fat and its influence on esophageal inflammation and dysplasia in patients with Barrett's esophagus.

Authors:  Eric M Nelsen; Yujiro Kirihara; Naoki Takahashi; Qian Shi; Jason T Lewis; Vikneswaran Namasivayam; Navtej S Buttar; Kelly T Dunagan; Ganapathy A Prasad
Journal:  Clin Gastroenterol Hepatol       Date:  2012-03-17       Impact factor: 11.382

7.  Potential roles of Helicobacter pylori treatment, body mass index and waist circumference in the causation of erosive esophagitis: a randomized clinical trial (HEROES-GERD).

Authors:  Felipe Mazzoleni; Luiz Edmundo Mazzoleni; Carlos Fernando de Magalhães Francesconi; Guilherme Becker Sander; Pâmela Schitz Von Reisswitz; Tobias Cancian Milbradt; Rafael da Veiga Chaves Picon; Diego Mendonça Uchoa; Laura Renata De Bona; Huander Felipe Andreolla; Helenice Pankowski Breyer; Ronaldo Spinato Torresini; Eduardo André Ott; André Castagna Wortmann; Alexandro de Lucena Theil; Jonathas Stifft; Raquel Petrucci Zenker; Candice Franke Krumel; Matheus Truccolo Michalczuk; Alexandre De Araujo; Ane Paula Canevese; Nadja Volpato; Cristiano André da Silva; Pedro Guilherme Schaefer; Natacha Fleck Titton; Larisse Longo; Maria Isabel Edelweiss; Daniel Simon; Nicholas Joseph Talley
Journal:  Int J Obes (Lond)       Date:  2019-06-13       Impact factor: 5.095

Review 8.  Influence of obesity on the risk of esophageal disorders.

Authors:  Jesper Lagergren
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-06       Impact factor: 46.802

9.  Different effects of dietary factors on reflux esophagitis and non-erosive reflux disease in 11,690 Korean subjects.

Authors:  Su Youn Nam; Bum Joon Park; Yeong-Ah Cho; Kum Hei Ryu; Il Ju Choi; Sohee Park; Young-Woo Kim
Journal:  J Gastroenterol       Date:  2016-11-15       Impact factor: 7.527

10.  Metabolic syndrome as a risk factor for Barrett esophagus: a population-based case-control study.

Authors:  Cadman L Leggett; Eric M Nelsen; Jianmin Tian; Cathy B Schleck; Alan R Zinsmeister; Kelly T Dunagan; G Richard Locke; Kenneth K Wang; Nicholas J Talley; Prasad G Iyer
Journal:  Mayo Clin Proc       Date:  2013-02       Impact factor: 7.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.